QuantumClean & ChemTrace will demonstrate how its ultra-high purity chamber tool part cleaning, proprietary coatings and microcontamination analytical testing can help reduce wafer fabrication Cost-of-Ownership (CoO). Solutions’ information is available during show hours at SEMICON Europa at the Messe München Exhibition Center in Munich, Germany from November 13 — 16, 2018 (booth A4510).
This “farm of the future”, built by systems integrator GrowStack working in conjunction with TCE Electrical Ltd., is the latest research initiative to be led by CHAP and Stockbridge Technology Centre (STC), a pioneer in experimental and applied horticulture research since the 1950s.
The scientists envision that such transient engineered technologies one day could complement or replace pharmaceutical treatments for a variety of medical conditions in humans. This type of technology, which the researchers refer to as a “bioresorbable electronic medicine,” provides therapy and treatment over a clinically relevant period of time and directly at the site where it’s needed, thereby reducing side effects or risks associated with conventional, permanent implants.
In mid-April 2018, more than 20 freshly machined, large, shiny chunks of 7050 and 7075 aluminum that would make up the primary structure of the chassis were collected in a cleanroom in Building 18 at JPL, along with about a hundred smaller secondary parts.
The researchers created a new technology design for field effect transistors, which are basic switching devices in computers and other electronic devices. Those types of transistors also are promising candidates for next generation nanodevices. They can offer better switching behavior for computers and devices compared with traditional field effect transistors.
The discovery of slow, low-energy electrons produced by the intense laser cluster interactions provides a missing link in scientists’ understanding of the process, and could explain why biomolecules are damaged. Intense laser cluster interactions were known to produce energetic ions and electrons, but now, in a paper published today in Physical Review Letters, researchers have revealed that relatively slow electrons or low-energy electrons are also produced in large quantities.
Lindström India launched its second line of business, called Cleanroom services in India to ensure the highest quality hygiene, safety and reliability which is most critical to customers in the pharmaceutical, food and electronics industry. Lindström’s cleanroom service ensures hygienic production facilities by providing garments serviced in cleanroom laundries which prevent contaminations during process hereby ensuring complete safety of the products being manufactured.
Work on the camera for the future Large Synoptic Survey Telescope (LSST) has reached a major milestone with the completion and delivery of the camera’s fully integrated cryostat. With 3.2 gigapixels, the LSST camera will be the largest digital camera ever built for ground-based astronomy. It’s being assembled at the Department of Energy’s SLAC National Accelerator Laboratory.
In a new study in the American Chemical Society journal ACS Nano, Rice materials scientist Jun Lou, graduate student and lead author Emily Hacopian and collaborators, including Tour, stress-tested rebar graphene and found that nanotube rebar diverted and bridged cracks that would otherwise propagate in unreinforced graphene.
The Controlled Environmental Solutions business is made up of highly specialized testing and certification services, control procedures and tailored decontamination technology for the clean room to ensure optimal performance of the environment and end-user compliance to highly regulated industry standards.
A next-generation biomanufacturing plant incorporates multiple innovative technologies into a single facility, and therefore is built in half the construction time with approximately one half of the operating cost of a traditional plant. The next-generation biomanufacturing plant require a smaller manufacturing footprint and offer greater environmental benefits, including reduced consumption of water and energy and lower levels of carbon emissions.
The U.S. Food and Drug Administration (FDA) has approved the first ever non-surgical treatment for the rare neuroendocrine cancers pheochromocytoma and paraganglioma. The approval was based on a multi-center trial led by researchers in the Abramson Cancer Center of the University of Pennsylvania and was granted to Progenics Pharmaceuticals for AZEDRA.